2014•Primary Health CareRequires access

Assessing GP use of varenicline therapy for smoking cessation

Vari M Drennan

Open publisher page 0 citations

Abstract

Smoking cessation is an important public health policy in reducing premature mortality in people with risk factors or comorbidities. Varenicline is the most effective therapy for sustained cessation, but it is not used as widely as nicotine replacement therapy.

About this research paper

What this paper is about

Smoking cessation is an important public health policy in reducing premature mortality in people with risk factors or comorbidities. Varenicline is the most effective therapy for sustained cessation, but it is not used as widely as nicotine replacement therapy.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Smoking cessation is an important public health policy in reducing premature mortality in people with risk factors or comorbidities. Varenicline is the most effective therapy for sustained cessation, but it is not used as widely as nicotine replacement therapy.

Key concepts: Varenicline, Smoking cessation, Nicotine replacement therapy, Medicine, Pharmacotherapy, Public health, Intensive care medicine, Psychiatry

Related papers

Back to paper searchBrowse research topicsOriginal source
Assessing GP use of varenicline therapy for smoking cessation — Research Paper | ScholarLens